MyJournals Home  

RSS FeedsRational identification of a Cdc42 inhibitor presents a new regimen for long-term hematopoietic stem cell mobilization (Leukemia)

 
 

25 september 2018 07:02:56

 
Rational identification of a Cdc42 inhibitor presents a new regimen for long-term hematopoietic stem cell mobilization (Leukemia)
 




 
58 viewsCategory: Pathology
 
Safety concerns of rivaroxaban use in APS (Nature Clinical Practice Rheumatology)
Correction: Mutant JAK3 phosphoproteomic profiling predicts synergism between JAK3 inhibitors and MEK/BCL2 inhibitors for the treatment of T-cell acute lymphoblastic leukemia (Leukemia)
 
 
blog comments powered by Disqus


MyJournals.org
The latest issues of all your favorite science journals on one page

Username:
Password:

Register | Retrieve

Search:

Pathology


Copyright © 2008 - 2024 Indigonet Services B.V.. Contact: Tim Hulsen. Read here our privacy notice.
Other websites of Indigonet Services B.V.: Nieuws Vacatures News Tweets Nachrichten